Pathogenesis of hepatocellular carcinoma

Area of Science:

• Hepatology
• Oncology
• Molecular Biology

Background:

• Hepatocellular carcinoma (HCC) is a prevalent global malignancy.
• Known risk factors and steps in hepatocarcinogenesis exist, but molecular interactions remain unclear.
• Chronic liver injury, regeneration, and cirrhosis contribute to malignant transformation.

Purpose of the Study:

• To elucidate the molecular mechanisms and sequential interactions of factors in HCC development.
• To identify novel diagnostic markers and therapeutic targets for HCC.
• To understand the genetic heterogeneity of HCC.

Main Methods:

• Review of current understanding of hepatocarcinogenesis.
• Discussion of molecular events including oncogene activation, tumor suppressor gene inactivation, and genomic instability.
• Highlighting the potential of new technologies like gene expression profiling and proteomics.

Main Results:

• HCC development is multifactorial, involving genetic alterations and altered gene expression.
• Significant genetic heterogeneity exists among HCC tumors.
• Chronic liver injury and associated cellular turnover are key contexts for malignant transformation.

Conclusions:

• Understanding the complex molecular interplay in HCC is crucial.
• Advanced technologies are essential for unraveling HCC pathogenesis.
• Identifying novel molecular targets holds promise for improved HCC management.